Status:
UNKNOWN
Embolism in COVID-19 Positive Patients
Lead Sponsor:
Afyonkarahisar Health Sciences University
Conditions:
COVID-19 Pneumonia
Embolism
Eligibility:
All Genders
18-95 years
Brief Summary
Covid-19 outbreak has caused death of millions of people because of not only the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection itself but also infection dependent complication...
Detailed Description
This study has conducted to find the possible links between genetic make up of ICU patients with severe Covid-19 and embolism. 13 polymorphisms and mutations that the investigators targeted are locate...
Eligibility Criteria
Inclusion
- being tested positive for Covid-19
- ICU patients developing severe pneumonia upon Covid-19 infection
Exclusion
- previously tested positive for genetic factors increasing thrombosis risk
- ICU patients developing severe emboli regardless of Covid-19 infection
Key Trial Info
Start Date :
March 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04910360
Start Date
March 5 2021
End Date
August 30 2022
Last Update
February 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
INTERGEN Genetics and Rare Diseases Diagnosis Research & Application Center
Ankara, Cankaya, Turkey (Türkiye), 06510